Drimva

AstraZeneca

Global Safety Program Lead (GSPL), Cell Therapy, Immunology

$288K–$432K

US - Gaithersburg - MD · Full-time · Posted Oct 15, 2026

Experience
Extensive experience required; no specific number of years stated.
Education
Medical degree or equivalent medical qualification.

About the job

Leads patient-safety strategy and benefit-risk decisions for immunology cell therapy programs from development through postmarketing, where applicable.

What you'll do

  • Own safety strategy, surveillance, and delivery for assigned assets and indications, including safety objectives, risk management, and safety communications.
  • Advise on clinical development and trial decisions, assess cell therapy risks, and represent Patient Safety in governance and regulatory interactions.
  • Lead, coach, and develop safety physicians and scientists while partnering with cross-functional teams and using digital and AI-enabled methods to support safety decisions.

What they ask for

  • Medical degree or equivalent medical qualification.
  • Extensive experience in clinical safety/pharmacovigilance and drug development.
  • Cell therapy experience, including direct involvement in clinical development and safety evaluation of cell or gene therapy programs.
  • Relevant clinical or drug-development experience in immunology or another field applicable to autoimmune cell therapy.

Nice to have

  • Board certification, specialty training, or substantial clinical experience in a relevant discipline.
  • PhD or another advanced degree in a relevant scientific discipline.

Pay

$288,059.20 - $432,088.80 USD (base pay)

AI focus

Use digital, data-visualization, and artificial-intelligence-enabled methods to strengthen safety surveillance, signal evaluation, knowledge integration, and decision-making.

Model-written summary · the original posting is authoritative

First seen Oct 28, 2026 · Last verified Nov 5, 2026 (UTC)